Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Izencitinib

Cat. No.: IBDI-431411

Izencitinib (TD-1473) is an orally active, non-selective and gut-restricted JAK inhibitor. Izencitinib (TD-1473) can be used in the study for ulcerative colitis.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target JAK
Molecular Weight 402.50
Appearance Solid
Synonyms TD-1473, JNJ-8398
SMILES CC1=CC(NC2=CC3=C(C=CC=N3)C(N[[email protected]@H]4C[[email protected]@H](CC5)N(CCC#N)[[email protected]@H]5C4)=N2)=NN1
Purity ≥98.0%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C, 3 years; 4°C, 2 years
In solvent: -80°C, 6 months; -20°C, 1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.